董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Suying Liu | 男 | Chairman, Chief Executive Officer, and Chief Financial Officer | 33 | 未披露 | 未持股 | 2021-06-29 |
| Todd Milbourn | 男 | Director | 52 | 未披露 | 未持股 | 2021-06-29 |
| Wenhua Zhang | 男 | Director | 51 | 未披露 | 未持股 | 2021-06-29 |
| Nelson Haight | 男 | Director | 56 | 未披露 | 未持股 | 2021-06-29 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Suying Liu | 男 | Chairman, Chief Executive Officer, and Chief Financial Officer | 33 | 未披露 | 未持股 | 2021-06-29 |
董事简历
中英对照 | 中文 | 英文- Suying Liu
-
Suying Liu，自2021年3月起担任Etao International Co., Ltd.董事长、首席执行官兼首席财务官。自2021年10月完成与Mountain Crest Acquisition Corp. II（Nasdaq：MCAD）的业务合并以来，Liu博士一直担任Better Therapeutics公司（Nasdaq：BTTX）的董事。自2020年7月起担任Mountain Crest收购公司董事长兼首席执行官，直至完成与Better Therapeutics公司的业务合并。自2021年3月起，他一直担任Mountain Crest Acquisition Corp. IV（纳斯达克代码：MCAF）董事长、首席执行官和首席财务官。自2021年4月起，他还一直担任Mountain Crest Acquisition Corp. V（纳斯达克股票代码：MCAG）的董事长、首席执行官和首席财务官。自2021年2月至2021年8月，PLBY Group, Inc.（纳斯达克股票代码：PLBY）与Mountain Crest Acquisition Corp（纳斯达克股票代码：MCAC）完成业务合并，Liu博士一直担任PLBY Group, Inc.董事。他从2019年11月起担任Mountain Crest Acquisition Corp的董事长兼首席执行官，直到Mountain Crest Acquisition Corp完成与PLBY Group, Inc.的业务合并。他在2020年5月至2020年9月期间担任Hudson Capital Inc.（纳斯达克股票代码：HUSN）的企业战略主管，领导公司在一般运营和特定增长领域的战略发展。在2018年11月至2020年4月期间，Liu博士担任Mansion Capital LLC的首席策略师，Mansion Capital LLC是一家私有房地产投资公司，拥有经纪和物业管理业务，为北美和亚洲客户在美国房地产市场的投资提供服务。在加入Mansion Capital之前，Liu博士曾于2015年7月至2018年10月在J.P. Morgan Chase & Co.担任投资策略师，为包括私人股本、对冲基金和保险公司在内的主要华尔街机构提供投资策略，主要关注商业抵押贷款。Liu博士的职业生涯始于学术界，2013年1月至2015年5月在华盛顿大学奥林商学院教授从学士到高管教育的各种学位课程，同时完成博士学业，并于2015年5月获得金融学博士学位。Liu博士于2012年12月获得金融学硕士学位，并于2010年5月以优异成绩获得圣路易斯华盛顿大学经济学和数学学士学位。
Suying Liu,has been Mountain Crest Acquisition Corp. V Chairman, Chief Executive Officer and Chief Financial Officer since April 2021. Dr. Liu was a director of PLBY Group, Inc. (Nasdaq: PLBY) from the closing of its business combination with Mountain Crest Acquisition Corp (Nasdaq: MCAC) in February 2021 until August 2021, and he served as the Chairman and Chief Executive Officer of MCAC between November 2019 and February 2021. He was a director of Better Therapeutics Inc. (Nasdaq: BTTX) since it closed its business combination with Mountain Crest Acquisition Corp. II (Nasdaq: MCAD) in October 2021 until April 2023, and he served as the Chairman and Chief Executive Officer of MCAD between July 2020 and October 2021. He was also a director of Etao International Co., Ltd. (Nasdaq: ETAO) since it closed its business combination with Mountain Crest Acquisition Corp. III (Nasdaq: MCAE) in February 2023 until March 2023, and he served as the Chairman and Chief Executive Officer, and Chief Financial Officer of MCAE between March 2021 and February 2023. He has been a director of CH AUTO Inc. since it closed its business combination with Mountain Crest Acquisition Corp. IV (Nasdaq: MCAF) in March 2024, and he served as the Chairman, Chief Executive Officer, and Chief Financial Officer of MCAF between March 2021 and March 2024. He served as the Head of Corporate Strategy of Hudson Capital Inc. (Nasdaq: HUSN) between May 2020 and September 2020, where he led the company's strategic development for both general operations and specific growth areas. Between November 2018 and April 2020, Dr. Liu served as the Chief Strategist of Mansion Capital LLC, a privately-held real estate investment firm with brokerage and property management operations serving clients from both North America and Asia for their investments in the U.S. real estate market. Prior to joining Mansion Capital, Dr. Liu was an investment strategist at J.P. Morgan Chase & Co. from July 2015 to October 2018, providing investment strategies to major Wall Street institutions spanning private equity, hedge funds and insurance companies, with a primary focus in commercial mortgages. Dr. Liu began his career in academia, teaching a variety of degree programs from bachelor's to executive education at Washington University Olin Business School between January 2013 and May 2015 while completing his doctoral studies, for which he received a PhD in finance in May 2015. Dr. Liu obtained a master's in finance in December 2012 and his BA in economics and mathematics summa cum laude in May 2010 from Washington University in St. Louis. - Suying Liu，自2021年3月起担任Etao International Co., Ltd.董事长、首席执行官兼首席财务官。自2021年10月完成与Mountain Crest Acquisition Corp. II（Nasdaq：MCAD）的业务合并以来，Liu博士一直担任Better Therapeutics公司（Nasdaq：BTTX）的董事。自2020年7月起担任Mountain Crest收购公司董事长兼首席执行官，直至完成与Better Therapeutics公司的业务合并。自2021年3月起，他一直担任Mountain Crest Acquisition Corp. IV（纳斯达克代码：MCAF）董事长、首席执行官和首席财务官。自2021年4月起，他还一直担任Mountain Crest Acquisition Corp. V（纳斯达克股票代码：MCAG）的董事长、首席执行官和首席财务官。自2021年2月至2021年8月，PLBY Group, Inc.（纳斯达克股票代码：PLBY）与Mountain Crest Acquisition Corp（纳斯达克股票代码：MCAC）完成业务合并，Liu博士一直担任PLBY Group, Inc.董事。他从2019年11月起担任Mountain Crest Acquisition Corp的董事长兼首席执行官，直到Mountain Crest Acquisition Corp完成与PLBY Group, Inc.的业务合并。他在2020年5月至2020年9月期间担任Hudson Capital Inc.（纳斯达克股票代码：HUSN）的企业战略主管，领导公司在一般运营和特定增长领域的战略发展。在2018年11月至2020年4月期间，Liu博士担任Mansion Capital LLC的首席策略师，Mansion Capital LLC是一家私有房地产投资公司，拥有经纪和物业管理业务，为北美和亚洲客户在美国房地产市场的投资提供服务。在加入Mansion Capital之前，Liu博士曾于2015年7月至2018年10月在J.P. Morgan Chase & Co.担任投资策略师，为包括私人股本、对冲基金和保险公司在内的主要华尔街机构提供投资策略，主要关注商业抵押贷款。Liu博士的职业生涯始于学术界，2013年1月至2015年5月在华盛顿大学奥林商学院教授从学士到高管教育的各种学位课程，同时完成博士学业，并于2015年5月获得金融学博士学位。Liu博士于2012年12月获得金融学硕士学位，并于2010年5月以优异成绩获得圣路易斯华盛顿大学经济学和数学学士学位。
- Suying Liu,has been Mountain Crest Acquisition Corp. V Chairman, Chief Executive Officer and Chief Financial Officer since April 2021. Dr. Liu was a director of PLBY Group, Inc. (Nasdaq: PLBY) from the closing of its business combination with Mountain Crest Acquisition Corp (Nasdaq: MCAC) in February 2021 until August 2021, and he served as the Chairman and Chief Executive Officer of MCAC between November 2019 and February 2021. He was a director of Better Therapeutics Inc. (Nasdaq: BTTX) since it closed its business combination with Mountain Crest Acquisition Corp. II (Nasdaq: MCAD) in October 2021 until April 2023, and he served as the Chairman and Chief Executive Officer of MCAD between July 2020 and October 2021. He was also a director of Etao International Co., Ltd. (Nasdaq: ETAO) since it closed its business combination with Mountain Crest Acquisition Corp. III (Nasdaq: MCAE) in February 2023 until March 2023, and he served as the Chairman and Chief Executive Officer, and Chief Financial Officer of MCAE between March 2021 and February 2023. He has been a director of CH AUTO Inc. since it closed its business combination with Mountain Crest Acquisition Corp. IV (Nasdaq: MCAF) in March 2024, and he served as the Chairman, Chief Executive Officer, and Chief Financial Officer of MCAF between March 2021 and March 2024. He served as the Head of Corporate Strategy of Hudson Capital Inc. (Nasdaq: HUSN) between May 2020 and September 2020, where he led the company's strategic development for both general operations and specific growth areas. Between November 2018 and April 2020, Dr. Liu served as the Chief Strategist of Mansion Capital LLC, a privately-held real estate investment firm with brokerage and property management operations serving clients from both North America and Asia for their investments in the U.S. real estate market. Prior to joining Mansion Capital, Dr. Liu was an investment strategist at J.P. Morgan Chase & Co. from July 2015 to October 2018, providing investment strategies to major Wall Street institutions spanning private equity, hedge funds and insurance companies, with a primary focus in commercial mortgages. Dr. Liu began his career in academia, teaching a variety of degree programs from bachelor's to executive education at Washington University Olin Business School between January 2013 and May 2015 while completing his doctoral studies, for which he received a PhD in finance in May 2015. Dr. Liu obtained a master's in finance in December 2012 and his BA in economics and mathematics summa cum laude in May 2010 from Washington University in St. Louis.
- Todd Milbourn
-
Todd Milbourn，自2021年3月起担任Etao International Co., Ltd.董事会成员。他于2020年1月至2021年2月担任Mountain Crest Acquisition Corp（Nasdaq：MCAC）董事会成员，并于2020年10月至2021年10月担任Mountain Crest Acquisition Corp. II（Nasdaq：MCAD）董事会成员。自2021年3月起，他一直担任Mountain Crest Acquisition Corp. IV（纳斯达克股票代码：MCAF）董事会成员。自2021年4月以来，他还一直担任Mountain Crest Acquisition Corp. V（纳斯达克股票代码：MCAG）的董事会成员。Milbourn博士是华盛顿大学奥林商学院的副院长兼休伯特·C·穆格和多萝西·R·穆格金融学教授，自2000年6月以来，他在该学院研究并建立了企业融资、高管薪酬和信用评级领域的学术项目。凭借在估值、企业融资、公司治理、高管薪酬和企业风险承担方面的专业知识，Milbourn博士作为专家被私营公司和美国司法部聘用，处理与公平回报率、违约损害赔偿和高管薪酬计划等相关的案件。Milbourn博士还是Oppenheimer公司Xanthus基金审计委员会的主任和主席，Oppenheimer公司是一家资产管理公司，有1000多名财务顾问，管理的资产超过900亿美元。Milbourn博士于1995年12月在印第安纳大学凯利商学院获得金融学博士学位，并于1991年5月在奥古斯塔纳学院获得经济学和数学学士学位。
Todd Milbourn,has been a member of Mountain Crest Acquisition Corp. V board of directors since April 2021. He served as a member of the board of directors of Mountain Crest Acquisition Corp (Nasdaq: MCAC) from January 2020 to February 2021. Dr. Milbourn served as a member of the board of directors of Mountain Crest Acquisition Corp. II (Nasdaq: MCAD) from October 2020 to October 2021. He served as a member of the board of directors of Mountain Crest Acquisition Corp. III (Nasdaq: MCAE) from March 2021 to February 2023. He also served as a member of the board of directors of Mountain Crest Acquisition Corp. IV (Nasdaq: MCAF) between March 2021 and March 2024. Dr. Milbourn is the Vice Dean and Hubert C. and Dorothy R. Moog Professor of Finance at Washington University Olin Business School, where he has researched and built academic programs in the areas of corporate finance, executive compensation and credit ratings since June 2000. With expertise on valuation, corporate finance, corporate governance, executive compensation and corporate risk-taking, Dr. Milbourn has been retained as an expert by private firms as well as the U.S. Department of Justice in cases related to fair rates of return, breach of contract damages and executive compensation programs, among others. Dr. Milbourn is also the Director and Chair of the Audit Committee of the Xanthus Fund at Oppenheimer, an asset management company with over 1,000 financial advisors and more than $90 billion assets under administration. Dr. Milbourn obtained his PhD in finance from Indiana University Kelly School of Business in December 1995 and BA in economics and mathematics from Augustana College in May 1991. - Todd Milbourn，自2021年3月起担任Etao International Co., Ltd.董事会成员。他于2020年1月至2021年2月担任Mountain Crest Acquisition Corp（Nasdaq：MCAC）董事会成员，并于2020年10月至2021年10月担任Mountain Crest Acquisition Corp. II（Nasdaq：MCAD）董事会成员。自2021年3月起，他一直担任Mountain Crest Acquisition Corp. IV（纳斯达克股票代码：MCAF）董事会成员。自2021年4月以来，他还一直担任Mountain Crest Acquisition Corp. V（纳斯达克股票代码：MCAG）的董事会成员。Milbourn博士是华盛顿大学奥林商学院的副院长兼休伯特·C·穆格和多萝西·R·穆格金融学教授，自2000年6月以来，他在该学院研究并建立了企业融资、高管薪酬和信用评级领域的学术项目。凭借在估值、企业融资、公司治理、高管薪酬和企业风险承担方面的专业知识，Milbourn博士作为专家被私营公司和美国司法部聘用，处理与公平回报率、违约损害赔偿和高管薪酬计划等相关的案件。Milbourn博士还是Oppenheimer公司Xanthus基金审计委员会的主任和主席，Oppenheimer公司是一家资产管理公司，有1000多名财务顾问，管理的资产超过900亿美元。Milbourn博士于1995年12月在印第安纳大学凯利商学院获得金融学博士学位，并于1991年5月在奥古斯塔纳学院获得经济学和数学学士学位。
- Todd Milbourn,has been a member of Mountain Crest Acquisition Corp. V board of directors since April 2021. He served as a member of the board of directors of Mountain Crest Acquisition Corp (Nasdaq: MCAC) from January 2020 to February 2021. Dr. Milbourn served as a member of the board of directors of Mountain Crest Acquisition Corp. II (Nasdaq: MCAD) from October 2020 to October 2021. He served as a member of the board of directors of Mountain Crest Acquisition Corp. III (Nasdaq: MCAE) from March 2021 to February 2023. He also served as a member of the board of directors of Mountain Crest Acquisition Corp. IV (Nasdaq: MCAF) between March 2021 and March 2024. Dr. Milbourn is the Vice Dean and Hubert C. and Dorothy R. Moog Professor of Finance at Washington University Olin Business School, where he has researched and built academic programs in the areas of corporate finance, executive compensation and credit ratings since June 2000. With expertise on valuation, corporate finance, corporate governance, executive compensation and corporate risk-taking, Dr. Milbourn has been retained as an expert by private firms as well as the U.S. Department of Justice in cases related to fair rates of return, breach of contract damages and executive compensation programs, among others. Dr. Milbourn is also the Director and Chair of the Audit Committee of the Xanthus Fund at Oppenheimer, an asset management company with over 1,000 financial advisors and more than $90 billion assets under administration. Dr. Milbourn obtained his PhD in finance from Indiana University Kelly School of Business in December 1995 and BA in economics and mathematics from Augustana College in May 1991.
- Wenhua Zhang
-
Wenhua Zhang，自2021年3月起担任Etao International Co., Ltd.董事会成员。他于2020年1月至2021年2月担任Mountain Crest Acquisition Corp（Nasdaq：MCAC）董事会成员，并于2020年10月至2021年10月担任Mountain Crest收购公司II（Nasdaq：MCAD）董事会成员。自2021年3月起，他一直担任Mountain Crest Acquisition Corp. IV（纳斯达克股票代码：MCAF）董事会成员。自2021年4月以来，他还一直担任Mountain Crest Acquisition Corp. V（纳斯达克股票代码：MCAG）的董事会成员。自2014年10月以来，Zhang先生一直是私人投资公司Azia Capital Fund LP的合伙人。Zhang先生的职业生涯始于金融行业，2001年8月至2008年5月在T. Rowe Price担任科技、媒体和电信行业股票研究副总裁，后于2008年7月至2010年12月加入Bain Capital，担任多空股票投资基金Brookside Fund的董事。2011年2月至2012年8月，Zhang先生在哈佛管理公司担任高级副总裁兼投资组合经理。哈佛管理公司是哈佛大学的全资子公司，负责管理哈佛大学的捐赠资产。2012年10月至2014年10月，他在Newport Asia LLC担任合伙人兼投资组合经理，代表机构、捐赠基金和家族理财室的客户投资于亚洲的高增长公司。2001年5月，Zhang先生在宾夕法尼亚大学沃顿商学院获得了金融和技术创新双专业的MBA学位。
Wenhua Zhang,has been a member of Mountain Crest Acquisition Corp. V board of directors since April 2021. He served as a member of the board of directors of Mountain Crest Acquisition Corp (Nasdaq: MCAC) from January 2020 to February 2021. Mr. Zhang served as a member of the board of directors of Mountain Crest Acquisition Corp. II (Nasdaq: MCAD) from October 2020 to October 2021. He served as a member of the board of directors of Mountain Crest Acquisition Corp. III (Nasdaq: MCAE) from March 2021 to February 2023. He also served as a member of the board of directors of Mountain Crest Acquisition Corp. IV (Nasdaq: MCAF) between March 2021 and March 2024. Mr. Zhang has been a Partner at Azia Capital Fund LP, a private investment firm, since October 2014. Mr. Zhang began his career in the financial industry as the Vice President of Equity Research in the technology, media and telecom sector with T. Rowe Price from August 2001 to May 2008, and later joined Bain Capital as Director of the Brookside Fund, a long short equity investments fund, between July 2008 and December 2010. From February 2011 to August 2012, Mr. Zhang was Senior Vice President and Portfolio Manager at Harvard Management Company, a wholly owned subsidiary of Harvard University charged with managing the university's endowment assets, and then as Partner and Portfolio Manager at Newport Asia LLC between October 2012 and October 2014, investing in Asia's high-growth companies on behalf of clients from institutions, endowments, and family offices. Mr. Zhang received an MBA with dual majors in finance and technology innovation from the Wharton School at the University of Pennsylvania in May 2001. - Wenhua Zhang，自2021年3月起担任Etao International Co., Ltd.董事会成员。他于2020年1月至2021年2月担任Mountain Crest Acquisition Corp（Nasdaq：MCAC）董事会成员，并于2020年10月至2021年10月担任Mountain Crest收购公司II（Nasdaq：MCAD）董事会成员。自2021年3月起，他一直担任Mountain Crest Acquisition Corp. IV（纳斯达克股票代码：MCAF）董事会成员。自2021年4月以来，他还一直担任Mountain Crest Acquisition Corp. V（纳斯达克股票代码：MCAG）的董事会成员。自2014年10月以来，Zhang先生一直是私人投资公司Azia Capital Fund LP的合伙人。Zhang先生的职业生涯始于金融行业，2001年8月至2008年5月在T. Rowe Price担任科技、媒体和电信行业股票研究副总裁，后于2008年7月至2010年12月加入Bain Capital，担任多空股票投资基金Brookside Fund的董事。2011年2月至2012年8月，Zhang先生在哈佛管理公司担任高级副总裁兼投资组合经理。哈佛管理公司是哈佛大学的全资子公司，负责管理哈佛大学的捐赠资产。2012年10月至2014年10月，他在Newport Asia LLC担任合伙人兼投资组合经理，代表机构、捐赠基金和家族理财室的客户投资于亚洲的高增长公司。2001年5月，Zhang先生在宾夕法尼亚大学沃顿商学院获得了金融和技术创新双专业的MBA学位。
- Wenhua Zhang,has been a member of Mountain Crest Acquisition Corp. V board of directors since April 2021. He served as a member of the board of directors of Mountain Crest Acquisition Corp (Nasdaq: MCAC) from January 2020 to February 2021. Mr. Zhang served as a member of the board of directors of Mountain Crest Acquisition Corp. II (Nasdaq: MCAD) from October 2020 to October 2021. He served as a member of the board of directors of Mountain Crest Acquisition Corp. III (Nasdaq: MCAE) from March 2021 to February 2023. He also served as a member of the board of directors of Mountain Crest Acquisition Corp. IV (Nasdaq: MCAF) between March 2021 and March 2024. Mr. Zhang has been a Partner at Azia Capital Fund LP, a private investment firm, since October 2014. Mr. Zhang began his career in the financial industry as the Vice President of Equity Research in the technology, media and telecom sector with T. Rowe Price from August 2001 to May 2008, and later joined Bain Capital as Director of the Brookside Fund, a long short equity investments fund, between July 2008 and December 2010. From February 2011 to August 2012, Mr. Zhang was Senior Vice President and Portfolio Manager at Harvard Management Company, a wholly owned subsidiary of Harvard University charged with managing the university's endowment assets, and then as Partner and Portfolio Manager at Newport Asia LLC between October 2012 and October 2014, investing in Asia's high-growth companies on behalf of clients from institutions, endowments, and family offices. Mr. Zhang received an MBA with dual majors in finance and technology innovation from the Wharton School at the University of Pennsylvania in May 2001.
- Nelson Haight
-
Nelson Haight，自2021年3月起担任Etao International Co., Ltd.董事会成员。他于2020年1月至2021年2月担任Mountain Crest Acquisition Corp（Nasdaq：MCAC）董事会成员，并于2020年10月至2021年10月担任Mountain Crest Acquisition Corp. II（Nasdaq：MCAD）董事会成员。自2021年3月起，他一直担任Mountain Crest Acquisition Corp. IV（纳斯达克股票代码：MCAF）董事会成员。自2021年4月以来，他还一直担任Mountain Crest Acquisition Corp. V（纳斯达克股票代码：MCAG）的董事会成员。Haight先生是石油和天然气行业的资深人士，拥有30多年的专业经验，目前担任Key Energy Services, Inc.的高级副总裁、首席财务官和财务主管，他于2020年6月加入Key Energy Services, Inc.。从2019年9月至2020年6月，Haight先生担任环境商品公司Element Markets，LLC的临时首席财务官。从2018年11月到2019年6月，Haight担任Epic Companies，LLC的临时首席财务官，这是一家家族办公室支持的油田服务公司。Epic Companies于2019年8月申请破产。在2017年7月至2018年9月期间，Haight先生是私人拥有的勘探和生产公司Castleton Resources，LLC的首席财务官。2011年12月至2017年7月，Haight先生在Midstates Petroleum Company，Inc.担任副总裁和首席财务官等各种职务。Midstates Petroleum Company，Inc.是一家成立于1993年的勘探和生产公司，专注于将现代钻井和完井技术应用于先前发现但尚未开发的碳氢化合物趋势中的石油/液体资源。2015年，Haight领导的团队为Midstates Petroleum筹集了6.25亿美元的新资金。Midstates Petroleum于2016年4月申请第11章破产保护，Haight先生在Midstates Petroleum成功重组并于2016年10月摆脱破产的过程中发挥了重要作用。Haight先生于1988年5月获得德克萨斯大学奥斯汀分校的MPA和BBA学位，是一名注册会计师和美国注册会计师协会会员。
Nelson Haight,is independent Director. Mr. Haight is a finance executive with over 30 years of professional experience, Mr. Nelson Haight currently serves as Executive Vice President and Chief Financial Officer of TEAM, Inc., (NYSE: TISI) which he joined in June 2022. Previously from June 2020 to June 2022, he served as Senior Vice President, Chief Financial Officer and Treasurer for Key Energy Services, Inc.. From September 2019 to June 2020, Mr. Haight was the interim Chief Financial Officer for Element Markets, LLC, an environmental commodities firm. From November 2018 to June 2019, Mr. Haight was the interim Chief Financial Officer for Epic Companies, LLC, a family office backed oilfield service company. Between July 2017 and September 2018, Mr. Haight was the Chief Financial Officer of Castleton Resources, LLC, a privately held exploration and production company. From December 2011 to July 2017, Mr. Haight served in various capacities from Vice President to Chief Financial Officer at Midstates Petroleum Company, Inc. Mr. Haight served as a member of the board of directors of Mountain Crest Acquisition Corp (Nasdaq: MCAC) from January 2020 to February 2021, and served as a member of the board of directors of Mountain Crest Acquisition Corp. II (Nasdaq: MCAD) from October 2020 to October 2021. He served as a member of the board of directors of Mountain Crest Acquisition Corp. III (Nasdaq: MCAE) from March 2021 to February 2023. He served as a member of the board of directors of Mountain Crest Acquisition Corp. IV (Nasdaq: MCAF) from March 2021 to March 2024. He has also been serving as a member of the board of directors of Mountain Crest Acquisition Corp. V (Nasdaq: MCAG) since April 2021. Mr. Haight received an MPA and BBA from the University of Texas at Austin in May 1988 and was a licensed Certified Public Accountant up until 2022. - Nelson Haight，自2021年3月起担任Etao International Co., Ltd.董事会成员。他于2020年1月至2021年2月担任Mountain Crest Acquisition Corp（Nasdaq：MCAC）董事会成员，并于2020年10月至2021年10月担任Mountain Crest Acquisition Corp. II（Nasdaq：MCAD）董事会成员。自2021年3月起，他一直担任Mountain Crest Acquisition Corp. IV（纳斯达克股票代码：MCAF）董事会成员。自2021年4月以来，他还一直担任Mountain Crest Acquisition Corp. V（纳斯达克股票代码：MCAG）的董事会成员。Haight先生是石油和天然气行业的资深人士，拥有30多年的专业经验，目前担任Key Energy Services, Inc.的高级副总裁、首席财务官和财务主管，他于2020年6月加入Key Energy Services, Inc.。从2019年9月至2020年6月，Haight先生担任环境商品公司Element Markets，LLC的临时首席财务官。从2018年11月到2019年6月，Haight担任Epic Companies，LLC的临时首席财务官，这是一家家族办公室支持的油田服务公司。Epic Companies于2019年8月申请破产。在2017年7月至2018年9月期间，Haight先生是私人拥有的勘探和生产公司Castleton Resources，LLC的首席财务官。2011年12月至2017年7月，Haight先生在Midstates Petroleum Company，Inc.担任副总裁和首席财务官等各种职务。Midstates Petroleum Company，Inc.是一家成立于1993年的勘探和生产公司，专注于将现代钻井和完井技术应用于先前发现但尚未开发的碳氢化合物趋势中的石油/液体资源。2015年，Haight领导的团队为Midstates Petroleum筹集了6.25亿美元的新资金。Midstates Petroleum于2016年4月申请第11章破产保护，Haight先生在Midstates Petroleum成功重组并于2016年10月摆脱破产的过程中发挥了重要作用。Haight先生于1988年5月获得德克萨斯大学奥斯汀分校的MPA和BBA学位，是一名注册会计师和美国注册会计师协会会员。
- Nelson Haight,is independent Director. Mr. Haight is a finance executive with over 30 years of professional experience, Mr. Nelson Haight currently serves as Executive Vice President and Chief Financial Officer of TEAM, Inc., (NYSE: TISI) which he joined in June 2022. Previously from June 2020 to June 2022, he served as Senior Vice President, Chief Financial Officer and Treasurer for Key Energy Services, Inc.. From September 2019 to June 2020, Mr. Haight was the interim Chief Financial Officer for Element Markets, LLC, an environmental commodities firm. From November 2018 to June 2019, Mr. Haight was the interim Chief Financial Officer for Epic Companies, LLC, a family office backed oilfield service company. Between July 2017 and September 2018, Mr. Haight was the Chief Financial Officer of Castleton Resources, LLC, a privately held exploration and production company. From December 2011 to July 2017, Mr. Haight served in various capacities from Vice President to Chief Financial Officer at Midstates Petroleum Company, Inc. Mr. Haight served as a member of the board of directors of Mountain Crest Acquisition Corp (Nasdaq: MCAC) from January 2020 to February 2021, and served as a member of the board of directors of Mountain Crest Acquisition Corp. II (Nasdaq: MCAD) from October 2020 to October 2021. He served as a member of the board of directors of Mountain Crest Acquisition Corp. III (Nasdaq: MCAE) from March 2021 to February 2023. He served as a member of the board of directors of Mountain Crest Acquisition Corp. IV (Nasdaq: MCAF) from March 2021 to March 2024. He has also been serving as a member of the board of directors of Mountain Crest Acquisition Corp. V (Nasdaq: MCAG) since April 2021. Mr. Haight received an MPA and BBA from the University of Texas at Austin in May 1988 and was a licensed Certified Public Accountant up until 2022.
高管简历
中英对照 | 中文 | 英文- Suying Liu
Suying Liu，自2021年3月起担任Etao International Co., Ltd.董事长、首席执行官兼首席财务官。自2021年10月完成与Mountain Crest Acquisition Corp. II（Nasdaq：MCAD）的业务合并以来，Liu博士一直担任Better Therapeutics公司（Nasdaq：BTTX）的董事。自2020年7月起担任Mountain Crest收购公司董事长兼首席执行官，直至完成与Better Therapeutics公司的业务合并。自2021年3月起，他一直担任Mountain Crest Acquisition Corp. IV（纳斯达克代码：MCAF）董事长、首席执行官和首席财务官。自2021年4月起，他还一直担任Mountain Crest Acquisition Corp. V（纳斯达克股票代码：MCAG）的董事长、首席执行官和首席财务官。自2021年2月至2021年8月，PLBY Group, Inc.（纳斯达克股票代码：PLBY）与Mountain Crest Acquisition Corp（纳斯达克股票代码：MCAC）完成业务合并，Liu博士一直担任PLBY Group, Inc.董事。他从2019年11月起担任Mountain Crest Acquisition Corp的董事长兼首席执行官，直到Mountain Crest Acquisition Corp完成与PLBY Group, Inc.的业务合并。他在2020年5月至2020年9月期间担任Hudson Capital Inc.（纳斯达克股票代码：HUSN）的企业战略主管，领导公司在一般运营和特定增长领域的战略发展。在2018年11月至2020年4月期间，Liu博士担任Mansion Capital LLC的首席策略师，Mansion Capital LLC是一家私有房地产投资公司，拥有经纪和物业管理业务，为北美和亚洲客户在美国房地产市场的投资提供服务。在加入Mansion Capital之前，Liu博士曾于2015年7月至2018年10月在J.P. Morgan Chase & Co.担任投资策略师，为包括私人股本、对冲基金和保险公司在内的主要华尔街机构提供投资策略，主要关注商业抵押贷款。Liu博士的职业生涯始于学术界，2013年1月至2015年5月在华盛顿大学奥林商学院教授从学士到高管教育的各种学位课程，同时完成博士学业，并于2015年5月获得金融学博士学位。Liu博士于2012年12月获得金融学硕士学位，并于2010年5月以优异成绩获得圣路易斯华盛顿大学经济学和数学学士学位。
Suying Liu,has been Mountain Crest Acquisition Corp. V Chairman, Chief Executive Officer and Chief Financial Officer since April 2021. Dr. Liu was a director of PLBY Group, Inc. (Nasdaq: PLBY) from the closing of its business combination with Mountain Crest Acquisition Corp (Nasdaq: MCAC) in February 2021 until August 2021, and he served as the Chairman and Chief Executive Officer of MCAC between November 2019 and February 2021. He was a director of Better Therapeutics Inc. (Nasdaq: BTTX) since it closed its business combination with Mountain Crest Acquisition Corp. II (Nasdaq: MCAD) in October 2021 until April 2023, and he served as the Chairman and Chief Executive Officer of MCAD between July 2020 and October 2021. He was also a director of Etao International Co., Ltd. (Nasdaq: ETAO) since it closed its business combination with Mountain Crest Acquisition Corp. III (Nasdaq: MCAE) in February 2023 until March 2023, and he served as the Chairman and Chief Executive Officer, and Chief Financial Officer of MCAE between March 2021 and February 2023. He has been a director of CH AUTO Inc. since it closed its business combination with Mountain Crest Acquisition Corp. IV (Nasdaq: MCAF) in March 2024, and he served as the Chairman, Chief Executive Officer, and Chief Financial Officer of MCAF between March 2021 and March 2024. He served as the Head of Corporate Strategy of Hudson Capital Inc. (Nasdaq: HUSN) between May 2020 and September 2020, where he led the company's strategic development for both general operations and specific growth areas. Between November 2018 and April 2020, Dr. Liu served as the Chief Strategist of Mansion Capital LLC, a privately-held real estate investment firm with brokerage and property management operations serving clients from both North America and Asia for their investments in the U.S. real estate market. Prior to joining Mansion Capital, Dr. Liu was an investment strategist at J.P. Morgan Chase & Co. from July 2015 to October 2018, providing investment strategies to major Wall Street institutions spanning private equity, hedge funds and insurance companies, with a primary focus in commercial mortgages. Dr. Liu began his career in academia, teaching a variety of degree programs from bachelor's to executive education at Washington University Olin Business School between January 2013 and May 2015 while completing his doctoral studies, for which he received a PhD in finance in May 2015. Dr. Liu obtained a master's in finance in December 2012 and his BA in economics and mathematics summa cum laude in May 2010 from Washington University in St. Louis.- Suying Liu，自2021年3月起担任Etao International Co., Ltd.董事长、首席执行官兼首席财务官。自2021年10月完成与Mountain Crest Acquisition Corp. II（Nasdaq：MCAD）的业务合并以来，Liu博士一直担任Better Therapeutics公司（Nasdaq：BTTX）的董事。自2020年7月起担任Mountain Crest收购公司董事长兼首席执行官，直至完成与Better Therapeutics公司的业务合并。自2021年3月起，他一直担任Mountain Crest Acquisition Corp. IV（纳斯达克代码：MCAF）董事长、首席执行官和首席财务官。自2021年4月起，他还一直担任Mountain Crest Acquisition Corp. V（纳斯达克股票代码：MCAG）的董事长、首席执行官和首席财务官。自2021年2月至2021年8月，PLBY Group, Inc.（纳斯达克股票代码：PLBY）与Mountain Crest Acquisition Corp（纳斯达克股票代码：MCAC）完成业务合并，Liu博士一直担任PLBY Group, Inc.董事。他从2019年11月起担任Mountain Crest Acquisition Corp的董事长兼首席执行官，直到Mountain Crest Acquisition Corp完成与PLBY Group, Inc.的业务合并。他在2020年5月至2020年9月期间担任Hudson Capital Inc.（纳斯达克股票代码：HUSN）的企业战略主管，领导公司在一般运营和特定增长领域的战略发展。在2018年11月至2020年4月期间，Liu博士担任Mansion Capital LLC的首席策略师，Mansion Capital LLC是一家私有房地产投资公司，拥有经纪和物业管理业务，为北美和亚洲客户在美国房地产市场的投资提供服务。在加入Mansion Capital之前，Liu博士曾于2015年7月至2018年10月在J.P. Morgan Chase & Co.担任投资策略师，为包括私人股本、对冲基金和保险公司在内的主要华尔街机构提供投资策略，主要关注商业抵押贷款。Liu博士的职业生涯始于学术界，2013年1月至2015年5月在华盛顿大学奥林商学院教授从学士到高管教育的各种学位课程，同时完成博士学业，并于2015年5月获得金融学博士学位。Liu博士于2012年12月获得金融学硕士学位，并于2010年5月以优异成绩获得圣路易斯华盛顿大学经济学和数学学士学位。
- Suying Liu,has been Mountain Crest Acquisition Corp. V Chairman, Chief Executive Officer and Chief Financial Officer since April 2021. Dr. Liu was a director of PLBY Group, Inc. (Nasdaq: PLBY) from the closing of its business combination with Mountain Crest Acquisition Corp (Nasdaq: MCAC) in February 2021 until August 2021, and he served as the Chairman and Chief Executive Officer of MCAC between November 2019 and February 2021. He was a director of Better Therapeutics Inc. (Nasdaq: BTTX) since it closed its business combination with Mountain Crest Acquisition Corp. II (Nasdaq: MCAD) in October 2021 until April 2023, and he served as the Chairman and Chief Executive Officer of MCAD between July 2020 and October 2021. He was also a director of Etao International Co., Ltd. (Nasdaq: ETAO) since it closed its business combination with Mountain Crest Acquisition Corp. III (Nasdaq: MCAE) in February 2023 until March 2023, and he served as the Chairman and Chief Executive Officer, and Chief Financial Officer of MCAE between March 2021 and February 2023. He has been a director of CH AUTO Inc. since it closed its business combination with Mountain Crest Acquisition Corp. IV (Nasdaq: MCAF) in March 2024, and he served as the Chairman, Chief Executive Officer, and Chief Financial Officer of MCAF between March 2021 and March 2024. He served as the Head of Corporate Strategy of Hudson Capital Inc. (Nasdaq: HUSN) between May 2020 and September 2020, where he led the company's strategic development for both general operations and specific growth areas. Between November 2018 and April 2020, Dr. Liu served as the Chief Strategist of Mansion Capital LLC, a privately-held real estate investment firm with brokerage and property management operations serving clients from both North America and Asia for their investments in the U.S. real estate market. Prior to joining Mansion Capital, Dr. Liu was an investment strategist at J.P. Morgan Chase & Co. from July 2015 to October 2018, providing investment strategies to major Wall Street institutions spanning private equity, hedge funds and insurance companies, with a primary focus in commercial mortgages. Dr. Liu began his career in academia, teaching a variety of degree programs from bachelor's to executive education at Washington University Olin Business School between January 2013 and May 2015 while completing his doctoral studies, for which he received a PhD in finance in May 2015. Dr. Liu obtained a master's in finance in December 2012 and his BA in economics and mathematics summa cum laude in May 2010 from Washington University in St. Louis.